ARCT - Arcturus Therapeutics Holdings Inc.
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 812.30M |
| Enterprise Value | 515.17M |
| Trailing P/E | 87.37 |
| Forward P/E | 2.48 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.03 |
| Price/Book (mrq) | 3.01 |
| Enterprise Value/Revenue | 1.84 |
| Enterprise Value/EBITDA | 4.38 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 2.61 |
| 52-Week Change 3 | 36.67% |
| S&P500 52-Week Change 3 | 1.77% |
| 52 Week High 3 | 33.80 |
| 52 Week Low 3 | 11.70 |
| 50-Day Moving Average 3 | 25.23 |
| 200-Day Moving Average 3 | 19.26 |
Share Statistics
| Avg Vol (3 month) 3 | 521.71k |
| Avg Vol (10 day) 3 | 386.44k |
| Shares Outstanding 5 | 26.56M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 22.93M |
| % Held by Insiders 1 | 13.83% |
| % Held by Institutions 1 | 81.50% |
| Shares Short (May 14, 2023) 4 | 3.32M |
| Short Ratio (May 14, 2023) 4 | 7 |
| Short % of Float (May 14, 2023) 4 | 16.72% |
| Short % of Shares Outstanding (May 14, 2023) 4 | 12.50% |
| Shares Short (prior month Apr 13, 2023) 4 | 2.81M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Nov 15, 2017 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:7 |
| Last Split Date 3 | Nov 15, 2017 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 30, 2022 |
| Most Recent Quarter (mrq) | Mar 30, 2023 |
Profitability
| Profit Margin | 39.59% |
| Operating Margin (ttm) | 27.51% |
Management Effectiveness
| Return on Assets (ttm) | 11.89% |
| Return on Equity (ttm) | 43.30% |
Income Statement
| Revenue (ttm) | 281.04M |
| Revenue Per Share (ttm) | 10.61 |
| Quarterly Revenue Growth (yoy) | 1,431.00% |
| Gross Profit (ttm) | 62.95M |
| EBITDA | 79.19M |
| Net Income Avi to Common (ttm) | 111.27M |
| Diluted EPS (ttm) | 3.98 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 327.94M |
| Total Cash Per Share (mrq) | 12.35 |
| Total Debt (mrq) | 33.17M |
| Total Debt/Equity (mrq) | 10.08 |
| Current Ratio (mrq) | 4.71 |
| Book Value Per Share (mrq) | 12.40 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 45.16M |
| Levered Free Cash Flow (ttm) | -11.12M |
© 2023 Yahoo. All rights reserved.